Literature DB >> 11509590

Expression of alpha(4)beta(7) integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells.

H Yoshida1, H Kawamoto, S M Santee, H Hashi, K Honda, S Nishikawa, C F Ware, Y Katsura, S I Nishikawa.   

Abstract

During embryogenesis, the Peyer's patch anlagen are induced by a cell population that produces lymphotoxin (LT) alpha(1)beta(2) following stimulation of IL-7Ralpha. In this study, we show that the LT-producing cell is localized within the IL-7Ralpha(+) and integrin alpha(4)beta(7) (alpha(4)beta(7))(+) population in the embryonic intestine. Lineage commitment to the LT producer phenotype in the fetal liver coincides with expression of alpha(4)beta(7). Before expression of alpha(4)beta(7), the potential of IL-7Ralpha(+) population to generate B cells is lost. However, the progenitors for T cells and LT producer cells reside in the IL-7Ralpha(+)alpha(4)beta(7)(+) cells, but during subsequent differentiation, the potential to give rise to T cells is lost. This IL-7Ralpha(+)alpha(4)beta(7)(+) population migrates to the intestine, where it induces the Peyer's patch anlagen. When stimulated with IL-15 or IL-3 and TNF, the intestinal IL-7Ralpha(+)alpha(4)beta(7)(+) population can differentiate into fully competent NK1.1(+) NK cells or CD11c(+) APCs. Expression of alpha(4)beta(7) is lost during differentiation of both lineages; IL-7Ralpha expression is lost during NK1.1(+) cells differentiation. A newly discovered lineage(-)IL-7Ralpha(+)c-Kit(+)alpha(4)beta(7)(+) population in the fetal liver is committed to T, NK, dendritic, and fetal intestinal LT producer lineage, the latter being an intermediate stage during differentiation of NK and dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509590     DOI: 10.4049/jimmunol.167.5.2511

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Turning on LIGHT.

Authors:  S W Granger; C F Ware
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?

Authors:  Tim Raine
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

Review 3.  New insights into the development of lymphoid tissues.

Authors:  Serge A van de Pavert; Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

4.  Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract.

Authors:  Javier Rangel-Moreno; Damian Carragher; Troy D Randall
Journal:  Inmunologia       Date:  2007

5.  Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues.

Authors:  Mi-Yeon Kim; Simona Rossi; David Withers; Fiona McConnell; Kai-Michael Toellner; Fabrina Gaspal; Eric Jenkinson; Graham Anderson; Peter J L Lane
Journal:  Immunology       Date:  2008-01-16       Impact factor: 7.397

Review 6.  Induction of intestinal lymphoid tissue formation by intrinsic and extrinsic signals.

Authors:  Daniela Finke
Journal:  Semin Immunopathol       Date:  2009-06-09       Impact factor: 9.623

7.  Two waves of distinct hematopoietic progenitor cells colonize the fetal thymus.

Authors:  Cyrille Ramond; Claire Berthault; Odile Burlen-Defranoux; Ana Pereira de Sousa; Delphine Guy-Grand; Paulo Vieira; Pablo Pereira; Ana Cumano
Journal:  Nat Immunol       Date:  2013-12-08       Impact factor: 25.606

Review 8.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 9.  Development of secondary lymphoid organs.

Authors:  Troy D Randall; Damian M Carragher; Javier Rangel-Moreno
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

10.  Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation.

Authors:  Serge A van de Pavert; Brenda J Olivier; Gera Goverse; Mark F Vondenhoff; Mascha Greuter; Patrick Beke; Kim Kusser; Uta E Höpken; Martin Lipp; Karen Niederreither; Rune Blomhoff; Kasia Sitnik; William W Agace; Troy D Randall; Wouter J de Jonge; Reina E Mebius
Journal:  Nat Immunol       Date:  2009-09-27       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.